Elevai Labs sees 2023 net revenue over $1.635M, up 113% y/y

Gross Profit Margin: Over 67.8% representing an increase of approximately 9.5% YoY, showcasing our enhanced operational efficiency. Account Growth: Over 75% growth in customer accounts YoY, reflecting strong market trust and expanded customer base. Jorda. Plews, Elevai’s CEO commented, “This year has been transformative for Elevai. Alongside our transition to a public company our strategic initiatives in 2023 have resulted in the doubling of our revenue as well as increased gross margins when compared to 2022. Our focus on the patient and doctor experience, operational efficiency and market expansion has not only driven this growth but also strengthened our position in the regenerative skincare space. We are proud of our team’s continued hard work and commitment to excellence, which is demonstrated in these preliminary results, and serves as the foundation for continued growth.”